These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9404972)

  • 41. Influence of high-dose aprotinin on hemostasis and blood requirement in orthotopic liver transplantation.
    Grosse H; Lobbes W; Frambach M; Ringe B; Barthels M
    Semin Thromb Hemost; 1993; 19(3):302-5. PubMed ID: 7689757
    [No Abstract]   [Full Text] [Related]  

  • 42. Preoperative coagulation screen does not predict intraoperative blood product requirements in orthotopic liver transplantation.
    Ritter DM; Rettke SR; Lunn RJ; Bowie EJ; Ilstrup D
    Transplant Proc; 1989 Jun; 21(3):3533-4. PubMed ID: 2662515
    [No Abstract]   [Full Text] [Related]  

  • 43. Viscoelastic Monitoring to Guide Hemostatic Resuscitation in Liver Transplantation Surgery.
    Blaine KP; Sakai T
    Semin Cardiothorac Vasc Anesth; 2018 Jun; 22(2):150-163. PubMed ID: 29099334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation.
    Himmelreich G; Hundt K; Bechstein WO; Rossaint R; Neuhaus P; Riess H
    Semin Thromb Hemost; 1993; 19(3):273-8. PubMed ID: 7689752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hemostasis in children undergoing liver transplantation.
    Carlier M; Van Obbergh LJ; Veyckemans F; de Kock M; de Beys CC; Lavenne-Pardonge E; Moulin D; Otte JB
    Semin Thromb Hemost; 1993; 19(3):218-22. PubMed ID: 8362251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Thromboelastography in liver transplantation, a comparison with conventional laboratory tests].
    Charvát J; Vychodil P; Kieslichová E; Smrcková I; Hlozánek I
    Cas Lek Cesk; 2004; 143(10):697-9; discussion 700. PubMed ID: 15584621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of conjugated estrogen in orthotopic liver transplantation.
    Frenette L; Cox J; Arnall M; Eckhoff D; Bynon S
    South Med J; 1998 Apr; 91(4):365-8. PubMed ID: 9563429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of Thrombelastography as a global monitor of hemostasis.
    Pivalizza EG
    Transfusion; 2019 Feb; 59(2):825. PubMed ID: 30727044
    [No Abstract]   [Full Text] [Related]  

  • 49. [Monitoring blood coagulation in larger liver operations].
    Groh J; Welte M; Azad SC; Kratzer MA
    Infusionsther Transfusionsmed; 1993 Aug; 20(4):173-9. PubMed ID: 8400798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemodynamic and metabolic changes in hepatic transplantation.
    Rettke SR; Janossy TA; Chantigian RC; Burritt MF; Van Dyke RA; Harper JV; Ilstrup DM; Taswell HF; Wiesner RH; Krom RA
    Mayo Clin Proc; 1989 Feb; 64(2):232-40. PubMed ID: 2646481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of aprotinin in orthotopic liver transplantation.
    Suárez M; Sangro B; Herrero JI; Picardi A; Páramo JA; Quiroga J; Pardo F; Cienfuegos J; Carrera J; Hidalgo F
    Semin Thromb Hemost; 1993; 19(3):292-6. PubMed ID: 7689754
    [No Abstract]   [Full Text] [Related]  

  • 52. Perioperative standards for the treatment of coagulation disorders and usage of blood products in patients undergoing liver transplantation used in the Clinic for Transplant Surgery in Wrocław.
    Łukaszewski MK; Chudoba P; Lepiesza A; Rychter M; Szyber P
    Adv Clin Exp Med; 2018 Sep; 27(9):1211-1215. PubMed ID: 30019867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coagulation management with factor concentrates in liver transplantation: a single-center experience.
    Kirchner C; Dirkmann D; Treckmann JW; Paul A; Hartmann M; Saner FH; Görlinger K
    Transfusion; 2014 Oct; 54(10 Pt 2):2760-8. PubMed ID: 24827116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coagulation and liver transplantation.
    Kang Y; Audu P
    Int Anesthesiol Clin; 2006; 44(4):17-36. PubMed ID: 17033477
    [No Abstract]   [Full Text] [Related]  

  • 55. "Goal-directed" transfusion management leads to distinct reduction of fluid requirement in liver transplantation.
    Gerlach H; Rossaint R; Bechstein WO; Blumhardt G; Neuhaus P; Falke K
    Semin Thromb Hemost; 1993; 19(3):282-5. PubMed ID: 7689753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation.
    Frenette L; Cox J; McArdle P; Eckhoff D; Bynon S
    Anesth Analg; 1998 Jun; 86(6):1183-6. PubMed ID: 9620500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antithrombin III replacement in orthotopic liver transplantation.
    Coccheri S; Palareti G
    Semin Thromb Hemost; 1993; 19(3):268-72. PubMed ID: 8362256
    [No Abstract]   [Full Text] [Related]  

  • 58. Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care.
    Klages M; Zacharowski K; Weber CF
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):245-9. PubMed ID: 26784352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnosis and treatment of intracardiac thrombosis during orthotopic liver transplantation.
    Planinsic RM; Nicolau-Raducu R; Eghtesad B; Marcos A
    Anesth Analg; 2004 Aug; 99(2):353-6, table of contents. PubMed ID: 15271704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bedside coagulation monitoring.
    Ammar T; Reich DL
    J Cardiothorac Vasc Anesth; 1995 Aug; 9(4):353-4. PubMed ID: 7579101
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.